Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
**Description:** 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine is a synthetic small molecule belonging to the phenylpyrimidine class. It has the molecular formula C16H11Cl2N5 and a molecular weight of approximately 344.20 g/mol[1][3][6]. The compound is primarily known as an experimental chemical probe and is not approved for clinical use in any country[6][7]. **Mechanism of Action:** The only reported protein target for this compound is Heat shock protein HSP90-alpha (HSP90AA1), but its pharmacological action remains unknown or uncharacterized[6][2]. There are no approved indications or clinical trials beyond preclinical/experimental research. **Development Status:** No evidence exists for therapeutic development or commercial manufacturing; it remains an experimental research tool.
- Other names
- 4-(2,4-dichlorophenyl)-5-phenyldiazenylpyrimidin-2-amine4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine338747-37-84-(2,4-dichlorophenyl)-5-phenyldiazenylpyrimidinamin4-(2,4-dichlorophenyl)-5-[ (E) -2-phenyldiazen -1 - yl ] pyrimidin - 2 - amine
02
Targets
HSP90AA1 (Heat shock protein HSP90-alpha)
Beyond the preview
Go deeper on 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine.